biotech

Southlake Biotech Renibus Therapeutics Garners $33M in Bridge Financing

by | Dec 8, 2022
Southlake-based Renibus Therapeutics—a clinical-stage biotech company developing innovative products for cardiorenal diseases—has received $33 million in bridge financing to help it advance three drugs in its pipeline. The drugs are currently in various phases of trials.
MORE
NanOlogy Sees ‘Encouraging Signs’ for Its Microparticle Drug Delivery in Nonoperable Lung Cancer Patients
by | Nov 20, 2022

Fort Worth-based NanOlogy has completed the enrollment of 18 patients in a Phase 2a trial for its proprietary particle drug delivery with standard-of care therapy in nonoperable lung cancer patients....

MORE
JLL’s DFW Life Science Snapshot: What’s Driving the North Texas Biotech Boom
by | Oct 4, 2022
The North Texas biotech boom just keeps booming—and a new "DFW Life Science Snapshot" from JLL shows why. From the Biotech+ Hub at Pegasus Park to a string of accelerators to local universities, DFW Airport, and more, here's a deep dive into what's behind the boom. "We are showing up in the rankings and in the data," says Mike Rosa of the Dallas Regional Chamber. "It results in more opportunities and more looks for us."
MORE
Form Bio Spins Out of Colossal Bioscience to Offer Scientists the ‘Missing Piece’
by | Sep 27, 2022
Dallas-based Colossal Biosciences, the de-extinction company behind plans to bring back the woolly mammoth and thylacine, developed its own software solution "after reviewing everything available on the market." Now it's sharing the platform with the launch of Form Bio.

The spinout's technology tools can help drive the “entire molecular revolution” that is occurring in the life sciences and biotech space, in addition to bolstering the Lone Star state as a hub for the industry, says Chief Strategy Officer Claire Aldridge.
MORE

Fueling the Biotech Boom: Dallas College Lands ‘Historic’ $8.8M Grant to Train Workers as North Texas’ Life Sciences Sector Soars

by | Aug 3, 2022
Top North Texas healthcare and life science employers—including UT Southwestern, McKesson, Evolve Biologics, Texas Health Resources, and more—have already signed up to hire 1,100 biotech workers from the groundbreaking program.

27,000 workers have made Dallas-Fort Worth a Top 20 U.S. metro for life sciences companies. As the boom continues, they’ll need company. Here's how the grant will help Dallas College and other local higher ed institutions step up to provide it—and why a CEO at Lyda Hill Philantrhopies calls it a "game changer."
MORE
At the Fourth Annual iC3 Life Science Summit at UT Arlington on Oct. 10, 2017 recipient Lyda Hill will present the award. To register for the summit, visit www.bionorthtx.org. [Illustration: bestbrk/istockphoto]
Dallas-Fort Worth Makes List of Top 20 Life Science Metros
by | Jul 8, 2022
See how the region ranked.
MORE
Dallas-Founded Biopharma Firm Raises $120M to Expand its Pipeline
by | Jun 29, 2022
ReCode Therapeutics, a biopharmaceutical startup using a non-viral lipid nanoparticle delivery platform for gene therapies, has closed a $120 million extension to a funding round it raised last year to help bring its lead programs to human trials and “follow the science” to target new diseases. With a research team working out of BioLabs' life sciences facility at Pegasus Park, ReCode aims to grow its global team from about 70 to 100 over the next year.
MORE
From right: DRC's Jorge Varela (far right) moderated a panel of industry experts including biotech C-level executive Hua Tu, Health Wildcatters CEO and co-founder Hubert Zajicek, and LH Capital Director Matt Crommett.
‘From a Trickle to a Waterfall’: How Biotech’s Flow is Growing in DFW
by | May 24, 2022
"It takes time" to establish a track record, Jorge Varela says, and the region is starting to see a series of biotech successes and spinoffs that will elevate the region's profile as a biotech hub.

According to a panel of experts at Urban Land Institute's 2022 spring meeting, here are factors drawing biotech to DFW.
MORE

North Texas Funders Initiative Will Train 300 Nonprofit Leaders to ‘Meet the Needs of Tomorrow’

by | Apr 27, 2022
Through a three-year partnership called the North Texas Funders Initiative, The Dallas Foundation and local leadership impact nonprofit RevJen Group, along with others including Lyda Hill Philanthropies, will bring leadership development training to over 300 nonprofit leaders each year.
MORE
TCU School of Medicine Is Building a New Campus in Fort Worth’s Medical District
by | Mar 1, 2022
The project will kick off with a four-story, approximately 100,000-square-foot medical education building, which TCU says will serve as an “academic hub” for around 240 students and hundreds of faculty and staff members, after its planned completion in 2024. At the new campus, TCU School of Medicine's innovative curriculum will continue—with students focused on major drivers of medicine's future, including AI, genomics, and advanced monitoring technology.
MORE
With New Funding and CEO, This Southlake Biotech is Looking to Solve Kidney Disease
by | Feb 16, 2022
Renibus Therapeutics, which focuses on treatments for acute and chronic kidney diseases, announced closing a $35 million Series A funding round. Its new CEO, Frank Stonebanks, says "Renibus has arrived at a critical inflection point in its commitment to transform the prevention and treatment of kidney diseases."
MORE
New Evolve Biologics Plant in Sachse Will Add 300 Jobs, Reinforcing DFW as a Biotech Hub
by | Dec 6, 2021
Mississauga, Ontario-based Evolve Biologics is a producer of plasma-derived therapeutics. The firm's CEO says the new, state-of-the-art, 200,000-SF Sachse facility "will be the foundation of our future growth and global strategy," with the capacity to process 1 million liters of plasma annually and a planned expansion to 2 million liters.
MORE

Alphabet Biotech Unit Verily to Open Dallas Operations Hub in Cypress Waters

by | Oct 14, 2021
It's the San Franciso company's first office in Texas. Verily expects to hire as many as 115 employees by the end of 2022.
MORE
OncoNano Expands Research Collaboration With UT Southwestern to Advance New Cancer Therapies
by | Sep 22, 2021
Southlake-based OncoNano Medicine uses pH-sensitive nanoparticle technology to "light up" cancer for real-time surgical imaging. The multi-year collaboration will seek to uncover new cancer therapies that can benefit from OncoNano's technology. OncoNano raised $50 million in Series B funding in June.
MORE
Nominate Now: BioNTX Dennis K. Stone Award Recognizes Positive Impact in North Texas Biotech and Life Science Research
by | Sep 14, 2021
Deadline for nominations is Friday, September 17. The 2021 award, sponsored by BioLabs at Pegasus Park, will be presented on September 30 at the iC3 Life Science Summit. The impact that Dr. Dennis K. Stone left on the DFW biotech industry is, without doubt, immeasurable, says BioNTX. Past recipients of the award that honors his memory are Phil Ralston, Lyda Hill, Darlene Boudreaux, Paul Dorman, and Hubert Zajicek.
MORE
Signature Biologics Expands Its Irving Footprint With a New Manufacturing and R&D Headquarters
by | Aug 25, 2021
There, Signature Biologics will manufacture perinatal-derived products that improve the body's natural healing processes in wound, musculoskeletal, and pain management applications.
MORE